NPM1
About
Location: 5q35.1
Mappings
Biomarkers
NPM1 is involved in the following curated biomarkers.
| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| NPM1 p.W288Cfs*12 | Somatic Variant | 5 | 5 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | NPM1 p.W288Cfs*12 | Acute Myeloid Leukemia | Ziftomenib | FDA |
| Sensitivity (+) | NPM1 p.W288Cfs*12 | Acute Myeloid Leukemia | Revumenib | FDA |
| Sensitivity (+) | NPM1 p.W288Cfs*12 | Acute Lymphoid Leukemia | Revumenib | FDA |
| Sensitivity (+) | NPM1 p.W288Cfs*12 | Burkitt Lymphoma | Revumenib | FDA |
| Sensitivity (+) | NPM1 p.W288Cfs*12 | Acute Leukemias of Ambiguous Lineage | Revumenib | FDA |